These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21781729)

  • 1. Validity and reliability of in vitro systems in safety evaluation.
    Paine AJ
    Environ Toxicol Pharmacol; 1996 Oct; 2(2-3):207-12. PubMed ID: 21781729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans.
    Dorne JL; Renwick AG
    Toxicol Sci; 2005 Jul; 86(1):20-6. PubMed ID: 15800035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data-derived safety factors for the evaluation of food additives and environmental contaminants.
    Renwick AG
    Food Addit Contam; 1993; 10(3):275-305. PubMed ID: 8359312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human variability and noncancer risk assessment- An analysis of the default uncertainty factor.
    Renwick AG; Lazarus NR
    Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 2):3-20. PubMed ID: 9618319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism, variability and risk assessment.
    Dorne JL
    Toxicology; 2010 Feb; 268(3):156-64. PubMed ID: 19932147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
    Dorne JL
    Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human variability in hepatic and renal elimination: implications for risk assessment.
    Dorne JL
    J Appl Toxicol; 2007; 27(5):411-20. PubMed ID: 17497760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of safety or uncertainty factors in the setting of acute reference doses.
    Renwick AG
    Food Addit Contam; 2000 Jul; 17(7):627-35. PubMed ID: 10983588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model systems and organisms for addressing inter- and intra-species variability in risk assessment.
    Rusyn I; Chiu WA; Wright FA
    Regul Toxicol Pharmacol; 2022 Jul; 132():105197. PubMed ID: 35636685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The speciation of metals in mammals influences their toxicokinetics and toxicodynamics and therefore human health risk assessment.
    Yokel RA; Lasley SM; Dorman DC
    J Toxicol Environ Health B Crit Rev; 2006; 9(1):63-85. PubMed ID: 16393870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of mechanisms and modes of toxic action for understanding tissue residue toxicity and internal effect concentrations of organic chemicals.
    Escher BI; Ashauer R; Dyer S; Hermens JL; Lee JH; Leslie HA; Mayer P; Meador JP; Warne MS
    Integr Environ Assess Manag; 2011 Jan; 7(1):28-49. PubMed ID: 21184568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.
    Oldenkamp R; Huijbregts MA; Ragas AM
    Crit Rev Toxicol; 2016; 46(3):261-78. PubMed ID: 26648512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical application of kinetic data in risk assessment--an IPCS initiative.
    Meek B; Renwick A; Sonich-Mullin C;
    Toxicol Lett; 2003 Feb; 138(1-2):151-60. PubMed ID: 12559699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review.
    Dorne JL; Walton K; Renwick AG
    Food Chem Toxicol; 2005 Feb; 43(2):203-16. PubMed ID: 15621332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.